Clover Health Investments (CLOV) Receivables - Other (2020 - 2024)

Clover Health Investments' Receivables - Other history runs 5 years deep, the most recent figure standing at $1.7 million for Q4 2024.

• Quarterly Receivables - Other fell 80.44% year-over-year to $1.7 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$5.1 million (up 52.86% YoY) and the FY2025 annual result came in at -$24000.0, down 200.0% from the prior year.
• Receivables - Other was $1.7 million for Q4 2024 at Clover Health Investments, down from $15.0 million in the prior quarter.
• Across five years, Receivables - Other topped out at $24.3 million in Q1 2023 and bottomed at -$8.8 million in Q4 2022.
• A 5-year average of $11.5 million and a median of $14.6 million in 2022 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2021 — Receivables - Other surged 2320.92% — and 2024, when it sank 80.44%.
• Clover Health Investments' Receivables - Other stood at -$4.0 million in 2020, then tumbled by 72.29% to -$6.8 million in 2021, then slipped by 28.6% to -$8.8 million in 2022, then soared by 200.37% to $8.8 million in 2023, then sank by 80.44% to $1.7 million in 2024.
• Business Quant data shows CLOV's Receivables - Other at $1.7 million in Q4 2024, $15.0 million in Q3 2024, and $21.2 million in Q2 2024.